PneuStep — MRI-safe motor makes robotic biopsies possibleApril 09, 2007Johns Hopkins Medicine engineers announce plastic, air- and light-driven device more precise than human hand Engineers at the Johns Hopkins Urology Robotics Lab report the invention of a motor without metal or electricity that can safely power remote-controlled robotic medical devices used for cancer biopsies and therapies guided by magnetic resonance imaging. The motor that drives the devices can be so precisely controlled by computer that movements are steadier and more precise than a human hand. "Lots of biopsies on organs such as the prostate are currently performed blind because the tumors are typically invisible to the imaging tools commonly used," says Dan Stoianovici, Ph.D., an associate professor of urology at Johns Hopkins and director of the robotics lab. "Our new MRI-safe motor and robot can target the tumors. This should increase accuracy in locating and collecting tissue samples, reduce diagnostic errors and also improve therapy." A description of the new motor, made entirely out of plastics, ceramics and rubber, and driven by light and air, was published in the February issue of the IEEE/ASME Transactions on Mechanotronics. The challenge for his engineering team was to overcome MRI's dependence on strong magnetic interference. Metals are unsafe in MRIs because the machine relies on a strong magnet, and electric currents distort MR images, says Stoianovici. The team used six of the motors to power the first-ever MRI-compatible robot to access the prostate gland. The robot currently is undergoing preclinical testing. "Prostate cancer is tricky because it only can be seen under MRI, and in early stages it can be quite small and easy to miss," says Stoianovici. The new Johns Hopkins motor, dubbed PneuStep, consists of three pistons connected to a series of gears. The gears are turned by air flow, which is in turn controlled by a computer located in a room adjacent to the MRI machine. "We're able to achieve precise and smooth motion of the motor as fine as 50 micrometers, finer than a human hair," says Stoianovici. The robot goes alongside the patient in the MRI scanner and is controlled remotely by observing the images on the MR. The motor is rigged with fiber optics, which feeds information back to the computer in real time, allowing for both guidance and readjustment. "The robot moves slowly but precisely, and our experiments show that the needle always comes within a millimeter of the target," says Stoianovici. This type of precision control will allow physicians to use instruments in ways that currently are not possible, he says. "This remarkable robot has a lot of promise-the wave of the future is image-guided surgery to better target, diagnose and treat cancers with minimally invasive techniques," says Li-Ming Su, M.D., an associate professor of urology and director of laparoscopic and robotic urologic surgery at the Brady Urological Institute at Hopkins. Johns Hopkins Medical Institutions |
|||||||||||||||||||||
| Related Biopsies Current Events and Biopsies News Articles Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. Researcher: 'Optical biopsy' for breast cancer increasingly accurate But women may not have to endure the medical costs, stress and potential complications that accompany such invasive biopsies forever. A University of Florida biomedical engineering researcher is making progress on an "optical biopsy" that has the potential to determine whether growths are cancerous without ever puncturing the skin. Green tea shows promise as chemoprevention agent for oral cancer, M. D. Anderson study finds Green tea extract has shown promise as cancer prevention agent for oral cancer in patients with a pre-malignant condition known as oral leukoplakia, according to researchers at The University of Texas M. D. Anderson Cancer Center. PMH finding may help some tonsil cancer patients avoid chemotherapy Clinical researchers at Princess Margaret Hospital (PMH) have confirmed that patients with oropharyngeal squamous cell cancer ("tonsil cancer") harbour a common type of human papilloma virus (HPV16), but also that such cancers are very sensitive to radiation. Geneticists Hunt for Scleroderma Triggers At its most benign, the autoimmune disease scleroderma can discolor parts of the skin of its sufferers. At its most pernicious, it can thicken and harden their skin, their blood vessels, and their internal organs before, in many cases, killing them. Moderate amounts of protein per meal found best for building muscle For thousands of years, people have believed that eating large amounts of protein made it easier to build bigger, stronger muscles. Take Milo of Croton, the winner of five consecutive Olympic wrestling championships in the sixth century BC: If ancient writers are to be believed, he built his crushing strength in part by consuming 20 pounds of meat every day. PMH clinicians map group at high risk for aggressive, 'hidden' prostate cancer Clinical researchers at Princess Margaret Hospital (PMH) can now answer the question that baffles many clinicians - why do some men with elevated prostate specific antigen (PSA) levels who are carefully monitored and undergo repeated negative biopsies still develop aggressive prostate cancer? Surgeons' unanimous consensus: Needle biopsy is gold standard for breast cancer diagnosis A special report published in the October issue of the Journal of the American College of Surgeons indicates that an alarming 35% of initial diagnostic breast biopsies in the United States are still being done using unnecessary open surgical techniques. New drug aims to 'seek and destroy' many types of cancer A new drug designed to "seek and destroy" common cancers such as breast, prostate, endometrial, pancreatic, ovarian, skin and testicular cancers is being tested at TGen Clinical Research Services (TCRS) at Scottsdale Healthcare. Molecular imaging holds promise for early intervention in common uterine cancer A promising new molecular imaging technique may provide physicians and patients with a noninvasive way to learn more information about a type of cancer of the uterus lining called "endometrial carcinoma"-one of the most common malignant female tumors. More Biopsies Current Events and Biopsies News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||